Veterinary Drugs Market to Worth US$ 27,570 Mn Gaining Impetus from Government Support | Fortune Business Insights

The Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Pune, India - May 16, 2019 /MarketersMedia/ —

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/veterinary-drugs-market-100171

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

Nevertheless, the rising number of meat consuming people and increasing demand for animal products such as milk, ghee, cheese, and eggs are creating better growth opportunities for the veterinary drugs market.

Governments are also imposing stringent regulatory measures for improving animal safety. Such policies will not only keep animals safe from diseases but also improve the quality of products we derive from them.

Asia Pacific to Exhibit Fastest Growth Rate

The rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in Asia Pacific.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Vendors are entering into strategic collaborations, merger and acquisitions, and new product launches in order to gain a strong foothold in the market. They are also investing huge sums into research and development strategies for the discovery of new drugs to prevent various diseases from occurring in animals. Some of the players operating in the veterinary drugs market are Bayer AG., Zoetis Animal Healthcare, Virbac S.A. Vetoquinol, Ceva, Vetoquinol S.A., Merial Animal Health, Merck Ltd., Elanco, Intervet Inc., and Boehringer Ingelheim International GmbH.

About Us

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com/

Source URL: https://marketersmedia.com/veterinary-drugs-market-to-worth-us-27570-mn-gaining-impetus-from-government-support-fortune-business-insights/513520

Source: MarketersMedia

Release ID: 513520

More News From Biz Daily Online

China launches STAR, tech stock market to boost industry

Jul 23, 2019

BEIJING — Trading starts Monday on a Chinese stock market for high-tech companies that play a key role in official development plans that are straining relations with Washington. Regulators have approved 25 companies in information technology and other fields seen by communist leaders as a path to prosperity and global influence for the Shanghai Stock Exchange's STAR Market. The market, modeled on the U.S.-based NASDAQ, reflects the ruling Communist Party's desire to channel private capital into its development plans. It gives small Chinese investors a chance to buy into tech industries that have mostly turned to Wall Street to sell...

Asian stocks fall ahead of monthly employment data in US

Jul 23, 2019

BEIJING — Asian stocks advanced Friday as investors waited for American employment data and details of U.S.-Chinese trade talks. Benchmarks in Shanghai, Tokyo and Hong Kong rose while South Korea's was unchanged. Investors looked ahead to monthly U.S. jobs data due out Friday, which are expected to be a factor in the Federal Reserve's decision this month on interest rates. The markets expect a solid 165,000 increase in non-farm payrolls. The central bank has said it is prepared to cut rates to shore up the U.S. economy if trade disputes crimp growth. Expectations are rising that central banks will adopt...

Asian shares gain, Shanghai up 2.4%, on Fed rate cut talk

Jul 23, 2019

BANGKOK — Asian shares are higher with the Shanghai benchmark up 2.4% on hopes that a meeting between President Donald Trump and his counterpart Xi Jinping next week might help ease trade tensions. The Thursday tracked modest gains on Wall Street. Tokyo's Nikkei 225 index added 0.6% to 21,462.86 while the Hang Seng in Hong Kong surged 1.2% to 28,545.23. Shanghai was up 2.4% to 2,987.12 while Australia's S&P ASX 200 picked up 0.6% to 6,687.40. India's Sensex advanced 0.4% to 39,277.17. Shares fell in Jakarta but rose slightly in Taiwan and elsewhere in Southeast Asia. Confirmation that Trump and...

Stock markets stabilize after tumble over trade dispute

Jul 23, 2019

BANGKOK — World stock markets turned higher on Tuesday, stabilizing after heavy losses on Wall Street, as investors monitor the escalating dispute between China and the U.S. over trade. The FTSE 100 in Britain rose 0.9% to 7,230, while France's CAC 40 advanced 1.2% to 5,324. Germany's DAX advanced 0.6% to 11,949. Futures augured an upbeat start on Wall Street, with the contract for the Dow Jones Industrial Average up 0.6% and that for the S&P 500, which on Monday suffered its biggest loss since January, adding 0.7%. Investors already rattled by mounting tensions between Beijing and Washington got an...

Shares mixed after trade tensions spark Wall Street sell-off

Jul 23, 2019

BANGKOK — Shares were marginally higher in Europe on Wednesday, despite broad losses in Asia and New York, after Germany reported stronger-than-expected industrial output data. Germany's DAX gained 0.3% to 12,125.80 following the report that industrial production rose 0.5 percent in March from the month before. The CAC 40 in France added 0.2% to 5,405.50, while Britain's FTSE 100 fell 0.1% to 7,253.71. U.S. futures edged higher, with the contract for the Dow Jones Industrial Average up 0.1% at 25,991.00. The S&P 500 future contract gained 0.1% to 2,892.50. A broad sell-off on Wall Street pulled the Dow 1.8%, or...

About Us

Biz Daily Online gives a complete understanding of the world of business to you. Get today’s business news and learn about the trends that are affecting every business here.

Contact us: sales[at]bizdailyonline.com

Subscribe Now!